Search

Your search keyword '"Leukemia, Myelogenous, Chronic, BCR-ABL Positive"' showing total 1 results
Start Over Descriptor "Leukemia, Myelogenous, Chronic, BCR-ABL Positive" Database Supplemental Index
1 results on '"Leukemia, Myelogenous, Chronic, BCR-ABL Positive"'

1. Cost-effectiveness of nilotinib, dasatinib and imatinib as first-line treatment for chronic myeloid leukemia in Colombia, 2012.

Author

Romero, Martín, Chávez, Diana, De los Ríos, Magalí, and Álvis-Guzmán, Nelson

Subjects
COST effectiveness, NILOTINIB, DASATINIB, IMATINIB, TREATMENT of chronic myeloid leukemia, PROTEIN-tyrosine kinase inhibitors, QUALITY of life, THERAPEUTICS
Abstract

Copyright of Biomédica: Revista del Instituto Nacional de Salud is the property of Instituto Nacional de Salud of Colombia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results